Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4721 - 4728 of 11616 results
Sustainable Investing Will Change the World
May 31, 2019| Blog| Viewpoint
Physician Affiliation Price Fixing Case Settled for $2.5 Million
May 31, 2019| Alert| Viewpoint
Federal Circuit Affirms that the ITC Cannot Investigate an FDCA Violation without the FDA’s say-so
May 30, 2019| Blog| Viewpoint
Maryland’s Prescription Drug Affordability Board Bill Set to Take Effect
May 28, 2019| Blog| Viewpoint
Claimants Need Not Record Complaints to Enforce Lien Dissolution Bonds Under
May 28, 2019| Blog| Viewpoint
CMS Finalizes Medicare Advantage and Part D Drug Pricing Rule
May 28, 2019| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.